Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Treatment of Erdheim-Chester disease with long-term high-dose interferon-α.
[erdheim-chester disease]
Erdheim-
Chester
disease
(
ECD
)
is
a
rare
non-
Langerhans
cell
histiocytosis
,
characterized
by
a
foamy
CD
68
+
,
CD
1
a-
histiocyte
tissue
infiltration
.
Efficacy
of
standard
doses
of
interferon-α-
2
a
(
IFN
α
)
has
been
suggested
in
a
small
series
but
with
variation
,
depending
on
the
organs
involved
.
Our
aim
was
to
report
our
single
-center
experience
about
the
use
of
high
-dose
IFN
α
in
ECD
.
Twenty
-
four
ECD
patients
have
received
high
-dose
IFNα
(
IFNα
≥
18
mIU
/
wk
or
pegylated-
IFNα
≥
180
μg
/
wk
)
.
IFN
α
efficacy
was
evaluated
clinically
and
morphologically
using
a
standardized
protocol
(
median
follow-up
19
months
)
.
Indication
for
treatment
was
central
nervous
system
and
/
or
heart
involvement
(
n
=
20
)
,
exophthalmos
(
n
=
1
)
,
and
standard-dose
IFNα
inefficacy
(
n
=
3
)
.
High
-dose
IFN
α
was
effective
in
16
patients
(
67
%
)
with
improvement
(
n
=
11
,
46
%
)
and
stabilization
(
n
=
5
,
21
%
)
.
Late
and
gradual
improvement
was
observed
during
prolonged
follow-up
in
most
patients
.
The
efficacy
of
high
-dose
IFN
α
was
dependent
on
the
organs
involved
:
central
nervous
system
and
heart
improvement
or
stabilization
occurred
in
7
/
11
(
64
%
)
and
11
/
14
(
79
%
)
patients
,
respectively
.
Six
patients
(
25
%
)
worsened
.
High
doses
of
IFN
α
were
well-tolerated
:
13
(
54
.
2
%
)
patients
had
side
effects
but
treatment
interruption
was
infrequent
(
n
=
3
,
12
.
5
%
)
.
High
-dose
IFN
α
may
be
effective
in
severe
ECD
.
Improvement
may
be
slow
,
and
high
-dose
IFNα
treatment
should
be
prolonged
.
Diseases
Validation
Diseases presenting
"central nervous system"
symptom
22q11.2 deletion syndrome
adrenomyeloneuropathy
alexander disease
aniridia
aromatase deficiency
canavan disease
child syndrome
classical phenylketonuria
congenital toxoplasmosis
cowden syndrome
cushing syndrome
cystinuria
dracunculiasis
erdheim-chester disease
fabry disease
gm1 gangliosidosis
hereditary cerebral hemorrhage with amyloidosis
hirschsprung disease
hodgkin lymphoma, classical
kabuki syndrome
kallmann syndrome
kindler syndrome
krabbe disease
lamellar ichthyosis
legionellosis
liposarcoma
malignant atrophic papulosis
monosomy 21
neonatal adrenoleukodystrophy
phenylketonuria
proteus syndrome
scrub typhus
severe combined immunodeficiency
sneddon syndrome
triple a syndrome
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom